{ event: "article_read", name: `EMPOWER Study in Saudi Arabia`, author: ``, tags: `Diabetes`, publication_date: ``, interaction_type: "content" } 
Read article Read article
EMPOWER Study in Saudi Arabia
Key highlights from the EMPOWER Study in Saudi Arabia
Related articles
Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens
An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.
Treatment simplification of complex insulin regimens in T2D
An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.
MAT-BH-2400507/v1/MAR2025